Detalhe da pesquisa
1.
M-protein diagnostics in multiple myeloma patients using ultra-sensitive targeted mass spectrometry and an off-the-shelf calibrator.
Clin Chem Lab Med
; 62(3): 540-550, 2024 Feb 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-37823394
2.
An automated workflow based on data independent acquisition for practical and high-throughput personalized assay development and minimal residual disease monitoring in multiple myeloma patients.
Clin Chem Lab Med
; 2024 Jun 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-38872409
3.
N-linked glycosylation of the M-protein variable region: glycoproteogenomics reveals a new layer of personalized complexity in multiple myeloma.
Clin Chem Lab Med
; 62(8): 1626-1635, 2024 Jul 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-38332688
4.
Advances in minimal residual disease monitoring in multiple myeloma.
Crit Rev Clin Lab Sci
; 60(7): 518-534, 2023 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-37232394
5.
Multiple Myeloma Minimal Residual Disease Detection: Targeted Mass Spectrometry in Blood vs Next-Generation Sequencing in Bone Marrow.
Clin Chem
; 67(12): 1689-1698, 2021 11 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-34643690
6.
Monitoring the M-protein of multiple myeloma patients treated with a combination of monoclonal antibodies: the laboratory solution to eliminate interference.
Clin Chem Lab Med
; 59(12): 1963-1971, 2021 11 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-34392637
7.
Dynamic monitoring of myeloma minimal residual disease with targeted mass spectrometry.
Blood Cancer J
; 13(1): 30, 2023 02 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-36828828
8.
Retrospective Longitudinal Monitoring of Multiple Myeloma Patients by Mass Spectrometry Using Archived Serum Protein Electrophoresis Gels and De Novo Sequence Analysis.
Hemasphere
; 6(8): e758, 2022 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-35935609